MINSK, 19 March (BelTA) – Businesses in Belarus and India are interested in implementing joint projects, Yelena Malinovskaya, Deputy Chairperson of the Belarusian Chamber of Commerce and Industry (BelCCI) said during the India-Belarus Pharmaceutical Business Forum in Minsk, BelTA has learned.
Yelena Malinovskaya noted that a representative delegation of Indian companies had recently visited Minsk, where productive B2B negotiations took place. More than 80 Belarusian enterprises participated in these meetings. In addition, over the past six months, a number of forums and events have been held involving both sides.
“The intensive bilateral business agenda fully reflects the mutual interest of Belarusian and Indian businesses in joint projects. Over the past three years, India has risen from 14th to 8th place among Belarus’ largest trading partners. In 2025 alone, mutual trade increased by 81%,” she added.
The forum focused on the pharmaceutical sector. “For both Belarus and India, pharmaceuticals are strategically important and among the most dynamically developing industries. In Belarus, over the past five years, the average annual growth rate of pharmaceutical production has exceeded 10%, and the geography of exports includes 30 countries. India is certainly a recognized global leader in pharmaceuticals: it accounts for around 10% of the world’s total pharmaceutical output. In 2025, its exports exceeded $15 billion. India ranks third in the world in terms of medicine exports to more than 200 countries and is known as the ‘pharmacy of the world’ for its high-quality generics,” Yelena Malinovskaya emphasized.
According to her, these figures clearly demonstrate the importance and potential of building mutually beneficial cooperation between Belarus and India. “According to forecasts, the global pharmaceutical market will double by 2035 and reach $3.5 trillion. We find India’s experience and practices in generic production, biopharmaceuticals, and deep integration into global supply chains extremely valuable. And Belarus offers Indian companies direct access to the large EAEU market,” she said. Yelena Malinovskaya also highlighted the long-standing ties between Belarus and India in medical education.
“The Belarusian Chamber of Commerce and Industry is willing to serve as a unifying platform and a connecting link between Belarusian and Indian companies. We have all the necessary tools: from contract expertise and certification of goods’ origin to partner search and organization of business missions,” she concluded.
Yelena Malinovskaya noted that a representative delegation of Indian companies had recently visited Minsk, where productive B2B negotiations took place. More than 80 Belarusian enterprises participated in these meetings. In addition, over the past six months, a number of forums and events have been held involving both sides.
“The intensive bilateral business agenda fully reflects the mutual interest of Belarusian and Indian businesses in joint projects. Over the past three years, India has risen from 14th to 8th place among Belarus’ largest trading partners. In 2025 alone, mutual trade increased by 81%,” she added.
The forum focused on the pharmaceutical sector. “For both Belarus and India, pharmaceuticals are strategically important and among the most dynamically developing industries. In Belarus, over the past five years, the average annual growth rate of pharmaceutical production has exceeded 10%, and the geography of exports includes 30 countries. India is certainly a recognized global leader in pharmaceuticals: it accounts for around 10% of the world’s total pharmaceutical output. In 2025, its exports exceeded $15 billion. India ranks third in the world in terms of medicine exports to more than 200 countries and is known as the ‘pharmacy of the world’ for its high-quality generics,” Yelena Malinovskaya emphasized.
According to her, these figures clearly demonstrate the importance and potential of building mutually beneficial cooperation between Belarus and India. “According to forecasts, the global pharmaceutical market will double by 2035 and reach $3.5 trillion. We find India’s experience and practices in generic production, biopharmaceuticals, and deep integration into global supply chains extremely valuable. And Belarus offers Indian companies direct access to the large EAEU market,” she said. Yelena Malinovskaya also highlighted the long-standing ties between Belarus and India in medical education.
“The Belarusian Chamber of Commerce and Industry is willing to serve as a unifying platform and a connecting link between Belarusian and Indian companies. We have all the necessary tools: from contract expertise and certification of goods’ origin to partner search and organization of business missions,” she concluded.
The forum was held at the initiative of the Pharmaceutical Export Promotion Council of India, whose delegation includes more than 60 Indian manufacturers of pharmaceuticals, cosmetics, and biological supplements. The program included presentations by Belarusian and Indian companies, discussions on current areas of trade and economic cooperation in the pharmaceutical sector, as well as B2B sessions with representatives of Indian enterprises.
Photos by Vitaly Pivovarchik/ BelTA
Follow us on:
